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Nonsurgical aesthetic procedures continue to grow in popularity; however, evidence-
based clinical practice guidelines that can assist providers when performing aesthetic 
treatments are lacking. This gap in practice can result in the increased prevalence of side 
effects from treatments that can compromise patient safety and result in increased 
litigation. The goal of this project was the development of a clinical practice guideline 
(CPG) that can be used by aesthetic providers to standardize care when performing 
nonsurgical aesthetic procedures that can ultimately improve provider knowledge, which 
would improve patient safety. This CPG sought to answer the practice-focused question 
involving whether the development of a CPG for aesthetic providers can increase their 
knowledge about delivering safe and consistent patient care. The Appraisal of Guidelines 
for Research & Evaluation (AGREE) II instrument was the guiding framework used to 
develop and appraise the CPG once it was developed. Based on the AGREE II CPG 
evaluation criteria, an expert review panel consisting of six professionals from the 
medical spa industry analyzed the CPG using the AGREE II appraisal tool. Feedback 
from the expert panel was used to modify the draft version of this CPG before completing 
and presenting the final draft. The expert panel recommended the CPG for future 
incorporation and use at the project site. By incorporating and using this CPG, aesthetic 
treatments can be standardized to help improve patient safety, reduce adverse events, and 
improve patient outcomes, which can positively impact social change at the project site as 
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Section 1: Nature of the Project 
Introduction 
Options and prevalence of nonsurgical aesthetic procedures continue to rise 
nationwide. With that rise, there is also an increase in the prevalence of botched 
procedures by inexperienced providers and those who do not follow safety guidelines set 
by state nursing and medical boards. There is also a lack of clear and up-to-date safety 
and legal guidelines governing nonsurgical aesthetic procedures. Inexperienced providers 
and lack of clear and concise guidelines and adherence to existing guidelines present 
challenges for the med-spa industry, providers, and patients. The goal of the project was 
to develop a clinical practice guideline (CPG) that can assist healthcare providers at a 
local med spa to safely and effectively perform nonsurgical aesthetic procedures. This 
project supports regulatory compliance, enhances provider practice, and improves patient 
outcomes and safety, which ultimately improves care practices in the field of aesthetics. 
In doing so, the CPG improves patient outcomes and helps prevent or reduce legal 
ramifications associated with healthcare providers’ noncompliance with their respective 
regulatory state licensing boards, with implications for positive social change.  
Problem Statement 
As advancements in nonsurgical medical aesthetics procedures continue to 
evolve, state and federal policies providing clear and up-to-date safety and legal 
guidelines for such procedures performed at medical spas by registered nurses (RNs), 
nurse practitioners (NPs), physician assistants (PAs), and physicians are limited or 
lacking. Botched procedures are being performed nationwide, resulting in irreversible 
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damages such as dermal burns, scarring, and even blindness, which often result from 
medical spa providers not following state guidelines (American Med Spa Association 
[AMSPA], 2018). As more people come forward with complications resulting from 
nonsurgical procedures performed by improperly trained providers, increased exposure 
through the media has resulted. As the publics’ awareness about more cases like these 
increases, state regulatory agencies have increased enforcement of state guidelines 
violations (AMSPA, 2018). Many medical spas and operators have faced legal 
ramifications due to a lack of proper supervision of medical treatments and improperly 
trained personnel (Goldberg, 2018). Noncompliance with state and federal laws and 
professional scope of practice compromise patient safety and increase litigation potential.  
The Medical Board of California (MBOC) and California Board of Nursing 
(CBON) require that an initial good faith exam (GFE) be performed and documented by a 
physician or an APRN (advanced practice registered nurse) (AMSPA, 2018). Physicians 
may delegate APRNs to perform the initial medical clearance GFE of a patient prior to 
the patient undergoing an aesthetic procedure (AMSPA, 2020; MBOC, 2020). The 
AMSPA (2018) said 37% of respondents to a survey related to the GFE admitted either 
the GFE was not being performed or that the physician, PA, or NP was not the one 
performing the initial exam. However, there are currently no guidelines for aesthetic 
providers regarding specifics of the GFE, also known as the medical clearance 
assessment, and postprocedural follow-up and evaluation for any future medical 
treatment that may be performed (AMSPA, 2018). The common belief among aesthetic 
providers is that they are complying with laws and regulations as long as they document 
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and detail procedures that were performed and patient outcomes. While some providers 
may admit to verbally reassessing patients before any medical procedure, this information 
is not documented in formal medical charts. This is also the case at the intended project 
site.  
For inexperienced medical spa owners, current laws are ambiguous in terms of 
what exactly constitutes physician supervision and delegation for RNs and NPs. This has 
led to inconsistencies in care that have compromised patient safety and care outcomes. 
This CPG improves patient and provider safety by ensuring that patients’ medical history 
is reviewed prior to each aesthetic treatment and provides an easy-to-use checklist to 
support the approach. This checklist allows the health care provider to know if all 
necessary steps were taken prior to providing treatment or if further action is needed. 
Developing a practice process that incorporates a medical history review and the 
completion of a preprocedural checklist during every patient visit improves patient care, 
patient safety, and nursing practice. 
Purpose Statement 
Through a review of literature, individual cases of wrongdoing, past and current 
lack of care oversight, and inadequate training were identified in this project. 
Customarily, patients receive medical clearance by their primary care physician (PCP) 
before a scheduled surgery that usually includes tests like blood work and an 
electrocardiogram (EKG) (Keshavan & Swamy, 2016). Although the procedures at 
medical spas are considered nonsurgical, similar protocols can be established to guide 
clinicians and standardize care practices. Medical spa providers must be mindful that the 
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majority of medical spa procedures being performed are medical treatments and hence 
should be governed by laws and regulations of standard procedures (SPs) to support 
compliance with their respective scope of practice (AMSPA, 2020). While healthcare 
professionals may perceive patient evaluations prior to any medical procedure as 
common sense, the consistent performance of such evaluations in the medical spa 
industry due to a lack of procedure protocols and/or lack of knowledge or experience 
regarding procedures being performed is questionable (AMSPA, 2018). At the intended 
project site, there is a lack of standardized care practice protocols that can assist staff in 
providing safe patient care and compliance with current national and state regulations and 
state scope of practice guidelines, resulting in a gap in practice. This DNP project was 
focused on the development of a CPG that can assist practitioners in providing safe and 
consistent care to reduce the practice gap. The project’s practice-focused question for this 
project was: Can the development of a CPG for aesthetic providers increase their 
knowledge about delivering safe and consistent patient care? The ultimate goals of 
practice protocols are to provide patients with safe and standardized care, prevent 
unwanted complications, and avoid legal ramifications (Adatto & Byrd, 2017). This 
practice protocol can standardize care,  increase provider knowledge, and improve patient 
outcomes,  which can positively impact patient outcomes. 
Nature of the Doctoral Project 
Due to limited literature about the nonsurgical aesthetic field, the AMSPA was 
established to help guide medical spa organizations and clinicians. As the leading source 
for policies and procedures in the medical spa industry, the AMSPA’s staff agreed to 
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support the proposed clinical project by providing information that would aid in the 
development of this project.  
A review of literature was conducted to support the clinical practice problem and 
guideline development using the Walden University Library to search various databases 
(CINAHL, ERIC, MEDLINE, PubMed, and BioMed Central). Search terms included: 
AGREE II, best practice, clinical practice guidelines, Melnyk and Fineout-Overholt 
rating system of hierarchy of evidence, theory in aesthetics, rules and regulations, 
medical spas in California, lawsuits with med spas, California med spa laws, California 
Board of Nursing, California Board of Medicine, good-faith exam, trouble for med spas, 
patient safety, safety in aesthetics, aesthetic dermatology, cosmetic dermatology, best 
practice, physician supervision, adverse events in aesthetics, and medical procedures by 
nurses. As an additional source of reference, the AMSPA provided updated information 
relevant to laws and regulations of medical spas in the state of California.  
This clinical practice project was focused on developing a CPG for the medical 
spa facility at the project site. Approval to conduct this project at the practice site was 
provided by the administrator and physician owner of the med spa. The Walden 
University Manual for Clinical Practice Guideline Development was used to support this 
project. I communicated with the site owner/physician, and a plan was established with 
measurable and attainable goals as identified in Walden University’s CPG project 
manual. The guideline was developed using The Appraisal of Guidelines for Research & 
Evaluation Instrument (AGREE II), which involves developing scope and purpose, 
stakeholder involvement, rigor or development, clarity of presentation, applicability, and 
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editorial independence. The AGREE II gives researchers guidance on the recommended 
context of a high quality CPG and has been used for many years by CPG developers. An 
expert review panel was formed to review the CPG. The expert panel consisted of one 
physician owner, the general manager, one PA, one NP, and two RNs. The expert panel 
was educated regarding the AGREE II instrument and its use. The panel was provided 2 
weeks to review the CPG and provide feedback. After review by the panel, the CPG was 
scored according to AGREE II scoring instructions and revised due to panel feedback.  
Evidence collected to support this CPG was organized and graded by the Melnyk 
and Fineout-Overholt rating system (MFRS) of hierarchy of evidence. The MFRS is a 
reference tool for researchers to grade the quality of evidence they are using to support 
their proposed project development. During the development of this CPG, the latest 
evidence-based literature was incorporated. The hierarchy of evidence rating systems 
helped me to determine the level of evidence of literature ranging from level I –VII with 
level I being of highest quality.  
Significance 
Stakeholders impacted by this doctoral project were the employees and the 
administrator/owner of the medical spa facility located in the western region of the 
United States. The facility employees impacted by this project were RNs, NPs, PAs, 
general management, and one physician. The administrator and physician owner of the 
medical spa supported this doctoral project. The administrator agreed that this doctoral 
project when disseminated can fill the current clinical practice gap at the med spa and can 
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assist employees in terms of following state guidelines. This project can improve patient 
outcomes while potentially reducing the chance of legal ramifications.  
Walden University (2018) defined positive social change as “a deliberate process 
of creating and applying ideas, strategies, and actions to promote the worth, dignity, and 
development of individuals, communities, organizations, institutions, cultures, and 
societies” (para. 2). This DNP project focused on developing a CPG to streamline care in 
a med spa setting and promote patient safety by reducing patient complications, 
improving patient outcomes, and ultimately preventing legal ramifications. This CPG can 
promote compliance with state and federal guidelines for med spa clinicians, ultimately 
improving patient safety and protecting clinicians, hence promoting positive social 
change. This CPG also benefits RNs, NPs, PAs, physicians, and medical spa 
organizations at the local, state, and national levels, and most importantly, patients at 
large.  
Summary 
Developing a CPG for aesthetic procedures assists clinicians in performing 
standardized procedures by improving patient outcomes while protecting and enhancing 
patient and clinician safety. This project can fill the gap in practice related to lack of 
available guidelines for clinicians to support improving patient care outcomes and safety 
during nonsurgical cosmetic procedures. As more nurses fill the needed demand for nurse 
injector positions, the field of aesthetics can continue to grow. This project allows nurses 
to positively impact social change through the advancement of evidence-based care. The 
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project aligns with the AMSPA’s policies and procedures related to aesthetic nonsurgical 
interventions in medical spas.  
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Section 2: Background and Context 
Introduction 
In the field of nonsurgical aesthetics, procedures primarily performed at medical 
spas lack clear and up-to-date guidelines on safety protocols and scope-of-practice for 
RNs, nonphysician providers, and physicians. This CPG provides a tool for such 
providers to have when performing nonsurgical aesthetic procedures to help improve 
patient safety while ensuring compliance with state and federal guidelines. The practice-
focused question for this project was: Can the development of a CPG for aesthetic 
providers increase their knowledge about delivering safe and consistent patient care?          
By following the CPG, healthcare providers can provide safer care and help reduce or 
prevent legal ramifications. In developing this CPG, concepts, models, and theories that 
inform and support evidence are discussed in this section. I also synthesized primary 
writings and clarified terms that may have multiple meanings pertaining to the CPG. This 
section also includes a summary of local evidence and context of the problem and 
relevance of the CPG to nursing practice. The role of the DNP student is also discussed.  
Concepts, Models, and Theories 
This CPG was developed using the AGREE II instrument, one of the most 
commonly used guideline appraisal tools for CPG development and evaluation. In 
developing this CPG, it was critical to analyze evidence in a review of literature and 
grade such evidence accordingly. The evidence was graded using the MFRS of hierarchy 
of evidence, which also allowed for prioritizing relevance of evidence in terms of the 
development of the CPG. To support the successful implementation of the CPG, the 
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theoretical domains framework (TDF) was included in the project and is also 
recommended to help guide clinicians after this project has been completedwhen 
implementing the changes. Implementation of this CPG using the TDF will support the 
recommendations to assist in the facilitation of the CPG. The TDF encourages CPG 
developers to analyze anticipated behavior changes of end-users to help determine how to 
better apply or disseminate the CPG. With every change project, it is expected that some 
level of resistance to change may exist, which further reinforces the importance of the 
TDF in anticipating such change before implementation. While many researchers may 
argue that common sense works just as well as theory when applying a CPG, more 
relevant studies have suggested that CPGs that included a guided theory had a higher 
chance of implementation success compared to those implemented without a guided 
theory (Taylor et al., 2014).  
AGREE II 
The AGREE II instrument is quantitative and allows researchers to develop cost-
effective high quality CPGs. The AGREE II details various factors that comprise an 
appropriate high-quality CPG. Researchers can use the AGREE II as a checklist to ensure 
they have fulfilled requirements of guideline development, which involves scope and 
purpose, stakeholder involvement, rigor or development, clarity of presentation, 
applicability, and editorial independence (Seto et al., 2017). Regarding rigor, the AGREE 
II details and evaluates systematic methods used to obtain evidence supporting the CPG 
and evaluates whether or not the CPG was first reviewed by an expert panel prior to its 
implementation or application to pilot studies (see Table 1).  
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Table 1 
Framework to Develop the CPG 
AGREE II Model 
Domain 1. Scope and Purpose 
1. The overall objective(s) of the guideline is (are) specifically described.  
2. The health question(s) covered by the guideline is (are) specifically 
described.  
3. The population (patient, public, etc.) to whom the guideline is meant to 
apply is specifically described.  
 
Domain 2. Stakeholder Involvement 
4. The guideline development group includes individuals from all 
relevant professional groups.  
5. The views and preferences of the target population (patients, public, 
etc.) have been sought.  
6. The target users of the guideline are clearly defined.  
 
Domain 3. Rigor of Development 
7. Systematic methods were used to search for evidence.  
8. The criteria for selecting the evidence are clearly described.  
9. The strength and limitations of the body of evidence are clearly 
described.  
10. The methods for formulating the recommendations are clearly 
described.  
11. The health benefits, side effects, and risks have been considered in 
formulating the recommendations.  
12. There is an explicit link between the recommendations and the 
supporting evidence.  
13. The guideline has been externally reviewed by experts prior to its 
publication.  
14. A procedure for updating the guideline is provided.  
 
Domain 4. Clarity of Presentation 
15. The recommendations are specific and unambiguous  
16. The different options for management of the condition or health issue 
are clearly presented.  
17. Key recommendations are easily identifiable.  
 
Domain 5. Applicability  
18. The guideline describes facilitators and barriers to its application.  
19. The guideline provides advice and/or tools on how the 
recommendations can be put into practice.  
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20. The potential resource implications of applying the recommendations 
have been considered.  
21. The guideline presents monitoring and/or auditing criteria.  
 
Domain 6. Editorial Independence 
22. The views of the funding body have not influenced the content of the 
guideline.  
23. Competing interests of guideline development group members have 
been recorded and addressed.  
 
 
Note. From “Appraisal of Guidelines for Research and Evaluation II,” by The AGREE 
Research Trust, 2013, pp. 6–8. Reprinted with permission.  
MFRS Hierarchy of Evidence 
 Using the MFRS hierarchy of evidence, researchers are able to perform a rapid 
critical appraisal of current evidence to determine level of evidence, quality of conducted 
research, and usefulness to practice. In this project, a study evaluation table (see 
Appendix A) was developed to divide hierarchy of evidence and answer applicable 
questions. The MFRS was used to determine the appropriate level of evidence for every 
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Table 2 
MFRS Rating System  
Evidence Type Level of Evidence 
Systematic review or meta-analysis Level I 
 








Case-control or cohort study 
 
Level IV 




Qualitative or descriptive study 
Level VI 
 
Expert opinion or consensus 
Level VII 
 
Note. From “Evidence-Based Practice in Nursing and Health Care: A Guide to Best 
Practice,” by Melnyk and Fineout-Overholt, 2011, p. 12. Reprinted with permission.  
 
TDF 
 To help improve the successful development of the CPG, the TDF was applied 
when teaching the expert panel about the content of the CPG and its significance. The 
TDF was originally developed to evaluate influences on the behavior of medical 
professionals going through change interventions in their specific organizations. When 
attempting to change behavior, it is vital to understand and anticipate desired changes in 
behavior (Atkins et al., 2017). Behavior scientists and researchers developed the TDF to 
reduce unsuccessful implementation of change through a theoretical approach. Although 
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this CPG has not yet been disseminated, it is expected that including the TDF enhanced 
the CPG and its AGREE II rating by the expert panel.  
Definition of Terms 
Throughout this CPG project, multiple terms are used, some of which may also be 
used interchangeably. Project terms defined:  
Clinician: A healthcare individual who is licensed to provide medical aesthetic 
treatments in their respective state. 
Good faith exam (GFE): Initial medical history review and examination of a 
patient that can only be performed by physicians or nonphysician providers.  
Healthcare Provider: A healthcare individual who is licensed to provide medical 
aesthetic treatments in their respective state.  
Injector: A healthcare individual who is licensed to provide medical aesthetic 
treatments in their respective state.  
Med spa: A medical spa usually positioned outside of a traditional physician’s 
medical office. It provides medical services and is owned and operated by a healthcare 
provider licensed to practice medicine in their respective state. 
Non-physician provider: Licensed nurse practitioners and physician assistants.  
Mini GFE: Title given for the CPG form proposed for use by all injectors in 
aesthetics prior to providing aesthetic treatments.  
Nurse injector: RNs and NPs working in the aesthetic field. 
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Relevance to Nursing Practice 
Existing Scholarship and Research 
In synthesizing the literature, Rossi et al. (2019) said there were increased adverse 
events involving nonsurgical cosmetic treatments performed by nonphysician providers 
and RNs, as compared to physician providers. In the study survey, the most common 
procedures received by participants included neuromodulator injections for wrinkles and 
injectable dermal fillers, which are the top two procedures performed at the intended site 
for this CPG project. Adverse events involving discoloration occurred at a greater rate 
with nonphysician providers (43.5%; N = 23) compared to physician providers (14.8%; N 
= 27). Dermal burns also occurred more frequently with nonphysician providers (34.8%) 
compared to physician providers (7.4%). Providers in the aesthetic industry are aware 
that dermal burns are possible side effects or complications from treatments such as 
chemical peels, laser hair removal, intense pulse light (IPL), and other laser devices for 
dermal treatments and not injectable neuromodulators and dermal fillers. Because dermal 
burns are not likely to result from injectable treatments, the higher percentage of adverse 
events from procedures as presented in Rossi et al. (2019) may not correlate to 
procedures actually provided by nonphysician clinicians. Training and experience in such 
procedures can significantly differentiate a good from a better injector. As it pertains to 
this CPG, it is vital that RNs remain cognizant of state guidelines and contact physicians 
if and when complications occur, which should be a standardized procedure and can be 
incorporated as a practice standard.  
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While collecting appropriate patient medical history before performing 
nonsurgical aesthetic procedures is a responsibility of all injectors, that information, if 
collected, is not being documented in the patient’s medical chart. This leads to lack of 
proof that this examination was done. More importantly, the lack of documentation 
leaves open the question of whether the best evidence-based patient care was performed. 
While state boards of nursing across the nation agree regarding requirements and 
documentation of GFEs for new clients entering a med spa, there seems to be a 
generalized assumption in the aesthetic field that no further medical history review is 
needed for up to 1 year for these patients. Hence, at the local site, only the initial GFE 
evaluation is documented annually, regardless of the number of follow-up visits the client 
may return to receive various cosmetic treatments thereafter. The patient is not asked 
about his or her medical history, additional medications, or changes in skin before future 
appointments after that annual GFE. From an added safety perspective, I found it 
important to document that I reviewed patients’ medical history for any changes prior to 
every patient visit. The CPG aims to address this consistent lack of documentation and 
medical history review that appears to be occurring due to a lack of knowledge by 
healthcare providers and administrative staff about the importance of documentation as 
well as a lack of appropriate CPGs. Werschler et al. (2015) shared that if patients answer 
yes to any dermatological conditions such as previous skin cancers, psoriasis, eczema, or 
acne, that yes answer usually warrants further discussion with the patient to help prevent 
complications associated with aesthetic procedures, particularly with the use of energy-
based devices.  
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Current state guidelines leave many ambiguities in terms of interpretation, leaving 
inexperienced injectors at risk of legal ramifications while reducing the safety of their 
patients. Ann and Wicklin (2020) offered that respondents working in the field of 
aesthetics rated a med spa to be more prone to adverse events than a traditional 
physicians’ office. Of the respondents, 95.8% believed that regulations should be stricter, 
while 84.3% admitted they would like more support and information from medical 
societies related to medical spas. 
Shallwani et al. (2019) said the use of the AGREE II instrument to appraise 
current CPGs related to the benefits of physical activity in cancer patients was 
instrumental in their study. Using the AGREE II to measure the quality of each domain in 
their CPG, Shallwani et al. (2019) were able to identify that their CPG was lacking in the 
domain of applicability. Using the AGREE II instrument, healthcare providers can also 
identify where their CPGs maybe lacking to help improve overall patient outcomes and 
quality of care.   
Standard Practices Used by Accrediting Organizations 
Vital to the medical spa industry is understanding the scope of practice of each 
profession and tailoring policies and procedures to comply with those scopes of practices. 
The MBOC and the CBON both operate under state guidelines that indicate the scope of 
practice for nurses and physicians.  
According to the California Nurse Practice Act (CNPA) Section 2725 (b, 4), in 
providing nursing care or overlapping functions between physicians and RNs in 
organized health care systems, the RN is responsible for: Observation of signs and 
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symptoms of illness, reactions to treatment, general behavior, or general physical 
condition, and determination of whether the signs, symptoms, reactions, behavior, or 
general appearance exhibit abnormal characteristics, and implementation, based on 
observed abnormalities, of appropriate reporting, or referral, or standardized procedures, 
or changes in treatment regimen in accordance with standardized procedures, or the 
initiation of emergency procedures (Nurse Practice Act, 2021).  
The MBOC said that physician supervision is required when specific procedures 
are being performed but does not clearly identify to what extent. Instead, the MBOC 
requires that NPs and RNs operate under a formally written standardized procedure (SP) 
agreement that is developed between the physician and the nurse, not the medical spa 
institution. Both the MBOC (Title 16, CCR Section 1379) and the CBON (Title 16, 
California Code of Regulations (CCR) section 1474) have jointly agreed on the 
requirements for these SPs. Section 1474 (7) requires SPs to: “Specify the scope of 
supervision required for performance of standardized procedure functions, for example, 
telephone contact with the physician” (MBOC, 2020, p. 2). Furthermore, Section 1474 
(2) requires the SPs to “Specify which standardized procedure functions registered nurses 
may perform and under what circumstances” (MBOC, 2020, p.2).  
Other Approaches Used For Medical Clearance 
In further researching literature on safety protocols for aesthetic procedures, the 
articles that exist refer specifically to the initial GFE with a total disregard to the 
discussion of any future pre-procedure examinations, which confirms the significant gap 
in the existing literature. More importantly, existing literature does not link the adverse 
  19 
 
events of nonsurgical procedures to the lack of pre-procedural health history 
examination; however, the literature has linked these adverse events with surgical 
procedures. Kim et al. (2015) argued that the majority of surgical adverse events are 
directly related to errors occurring before or after the procedure and not during it. 
Furthermore, Kim et al. (2015) emphasized that failures or breakdowns in 
communication within and amongst the surgical team, patients, and their families were 
key factors that may have been eliminated with pre-procedural health histories. Chhabra 
et al. (2019) and Kim et al. (2015) said that interventions such as the World Health 
Organization’s (WHO) pre-operative checklist and Reason’s Swiss Cheese Model 
(RSCM) have helped prevent or reduce surgical adverse events. The WHO pre-operative 
checklist focuses on four areas of improvement including safety, and the prevention of 
surgical site infections. According to Chhabara et al. (2019) operating room employees 
are given a checklist consisting of questions that guide the surgeon and assists staff on 
what steps to take prior to anesthesia and skin incision, as well as after surgery. This CPG 
also provides clinicians with a checklist to use prior to performing nonsurgical 
treatments. Using the RSCM, accidents and mistakes in surgery were significantly 
reduced as it helped prevent one error from becoming prolonged throughout the surgical 
process. In short, a process is completed in a particular order before moving forward, 
hence preventing errors from prematurely advancing in the process. This CPG also has 
similar attributes to help limit the number of errors made by aesthetic providers in an 
effort to standardize pre-procedure protocols. This CPG requires providers to answer 
specific questions before they can move on to the next question. 
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Advances to Nursing Practice 
 The CPG aligns with the American Association of Colleges of Nursing DNP 
Essentials by advancing nursing practice, empowering nurses to provide evidence-based 
practice, while ensuring patient safety of the highest level in the field of aesthetics 
(Garritano et al., 2016). With implementation, the CPG aims to streamline and 
standardize provider practice, improve patient safety, and reduce the legal ramifications 
for injectors. The development of a CPG such as this by an NP can advance nursing 
practice by providing a quality evidence-based project that can easily be implemented by 
nurses and other providers practicing in the field of aesthetics. As more aesthetic patients 
present to the local med spa with complaints of bleeding and bruising resulting from 
aesthetic procedures, the CPG can guide current and future injectors on the steps 
necessary to break the cycle of reviewing a patient’s medical history once per year but 
rather review the medical history prior to every aesthetic procedure. The CPG requires 
injectors to screen patients for medications and medical history that may place patients at 
a higher risk of bleeding or bruising during aesthetic procedures.   
Local Background and Context 
It is important that injectors review and use the guidelines developed from other 
specialties, which can be customized for the aesthetic nonsurgical field. To help improve 
provider knowledge, improve patient outcomes and safety, and reduce adverse events, the 
CPG helps to fill this gap in the literature and practice. Kim et al. (2015) believes that 
while errors may always occur, as a change agent, it is essential to reinforce a change 
such as the CPG to help eliminate the tolerance of unsafe practice and align providers 
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with safer practices. At the local site, a once-yearly GFE is being performed and 
documented by a physician or non-physician provider prior to a patient’s initial medical 
treatment. The problem that exists at the local site is that providers are not performing a 
review of the patient’s medical history prior to performing every aesthetic procedure. 
Additionally, if an injector asks certain patient questions or performs a medical history 
review prior to treatment, it was not being documented. A known practice reality is that a 
patient’s medical history may change from one day to the next; hence, the reliance on a 
once-yearly GFE by a health care provider may not be of value to a patient seeking 
treatment throughout the year. More importantly, healthcare providers practicing 
according to their respective licensures, would be assessing and evaluating the patient’s 
medical history prior to each surgical and nonsurgical event to look for possible 
contraindications to treatment. While multiple med spa settings could be practicing the 
same bad habits, injectors could help break this cycle by implementing a practice 
protocol or this CPG at their respective practice site. A review of a patient’s medical 
history and pre-procedural instructions before a medical treatment has been shown to 
reduce adverse events and side effects (Chhabra et al., 2019; Kim et al., 2015; Werschler 
et al., 2015).  
The estimated time it takes a clinician to perform a mini-GFE for a patient is 
about 30-60 seconds, as long as no potential adverse contraindications were identified 
needing further explanation. A significant component of the CPG requires clinicians to 
document whether or not an initial GFE had ever been performed, which is mandated 
nation-wide. Other steps in the CPG ensure that clinicians educate their patients about 
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measures to reduce the risk of bleeding and bruising by avoiding certain commonly used 
substances prior to their next appointment. The CPG will also include substances to 
avoid, including non-steroidal anti-inflammatories (NSAIDs), alcohol, and some herbal 
supplements like gingko biloba, folic acid, turmeric, and fish oil.  
The local project site is a med spa located in the Western region of the United 
States. The staff includes three medical assistants (MA), four receptionists, two NPs, one 
PA, one general manager, one human resources manager, three RNs, and one medical 
doctor (MD). Of the 16 employees, seven are licensed and able to provide aesthetic 
medical treatments (RNs, NPs, & MD). Currently, none of these injectors use a written 
CPG or similar protocol as a guide when providing medical treatments. At the project 
site, the organization’s vision is to provide quality aesthetic procedures at affordable 
prices that are less than the current average prices in the surrounding area. This vision is 
geared towards giving individuals, who may not have otherwise had the finances, the 
opportunity to obtain aesthetic procedures, alleviating the financial difference through 
providing care to a higher volume of patients. The spa operates six days per week with an 
average of nine hours per day. The organization services an average of about 100 patients 
per week that present for medical aesthetic services.  
Role of the DNP Student 
As a DNP student, I served as the developer and project manager of this CPG. I 
am a registered family nurse practitioner (FNP) with over 10 years of experience in the 
healthcare field and 4 years of experience in nonsurgical aesthetic treatments. I received 
my Bachelors in Science of Nursing (BSN) from Wayne State University in Detroit, MI 
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in 2010 and my Master of Science in Nursing (MSN) from South University in Novi, MI 
in 2016. I have extensive experience and hold certifications in performing many aesthetic 
procedures such as laser treatments, the injections of dermal fillers, botulinum toxins, 
platelet-rich plasma, deoxycholic acid, and many others for the treatment of fine lines, 
wrinkles, fat pads, and volume loss. As an experienced leader in the field of aesthetic 
services at the project site, I am aware of the need to standardize the treatment process for 
aesthetic procedures. My experiences afforded me the ability to develop a CPG, and I 
attained full support of the organization’s administrators, staff, and other end-users. I 
moved from Detroit, Michigan in late 2018 to the Western region of the United States 
primarily because of my passion and love for the field of aesthetic. My passion and 
leadership position at the project site may be construed as a bias; however, that bias 
affords me the opportunity to make positive social change in generating and translating 
the much-needed evidence into practice, especially where patient outcomes and safety are 
a concern. Compared to the Eastern part of the nation, the West provided a more 
significant chance and opportunity to advance my aesthetic skills through exposure to the 
latest and greatest in aesthetic devices and procedures in a rapidly growing field. This 
experience has laid the foundation for my growth and reputation as an expert in aesthetic 
procedures.  
Summary 
Having the reputation, credentials, and experience in aesthetic procedures further 
supported my ability to recognize the existing practice gap and the need for this CPG. 
Providers at the local project site continue to perform aesthetic procedures based on 
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routine habits with limited information on safety and the respective state board 
regulations. As a trusted tool in research and guideline development, the AGREE II tool 
was used to evaluate the guideline from multiple perspectives. Developing this CPG has 
helped improve the knowledge of injectors in aesthetics, which can translate to providing 
safer treatments to patients. If implemented, the CPG can help standardize aesthetic 
procedures, build cultural confidence in the improved safety protocols of aesthetic 
treatments, and improve overall patient outcomes. Furthermore, the MFRS of hierarchy 
of evidence was used to analyze and evaluate the latest evidence that was used in the 
project in regard to relevance and strength. While there are existing guidelines for 
surgical treatments, the nonsurgical field lacks evidence and guidelines that can be used 
to support nonsurgical procedures. Hence, reviewing and analyzing surgical guidelines 
influenced and assisted me in the development of this CPG for nonsurgical procedures. 
Incorporating the mini GFE as a component of the CPG may also help build a trusting 
relationship between the injector and the patient, especially when time is taken to explain 
that the reason for the mini GFE is to ensure a higher level of safety before treatments. In 
a very busy med spa such as the local project site, time is of the essence, but safety must 
always come first, safety that the implementation of the CPG will significantly improve. 
While the CPG is an adjunct guideline, it is not to be considered a replacement to the 
initial GFE that is required to be completed by a physician or non-physician provider. 
Further analysis and synthesis of evidence will be discussed to justify the need and 
provide more comprehensive support for this CPG project and its application in practice.  
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Section 3: Collection and Analysis of Evidence 
Introduction 
With the rapid growth and prevalence of nonsurgical aesthetic treatments, more 
RNs than ever have made their career in the field of aesthetics. An increase in aesthetic 
treatments has also facilitated the growth of various options, products, and machines that 
are readily available at many local medical spas. While there is no unique governing 
body or state board specific to aesthetics, RNs, NPs, and physicians must always practice 
according to their respective licensing boards and guidelines.  
Unfortunately, with the rapid growth of the aesthetic field, state and federal 
guidelines continue to be lacking with respect to safety and scope of practice for aesthetic 
injectors. Consequently, botched procedures and adverse events from such procedures are 
also rising (AMSPA, 2018). In fact, the lack of supervision of medical treatments by 
physicians, as well as lack of training of injectors, has been the primary cause of legal 
ramifications due to adverse events for patients undergoing such treatments.  
 The purpose of this DNP project was to develop a CPG that would help improve 
knowledge of aesthetic injectors and standardize the treatment process prior to providing 
medical treatments for patients. Evidence-based CPGs have become a foundation in 
research, bridging the gap between literature on best policy, local context, and patient 
choice. Adatto and Byrd (2017) said that the Institute of Medicine (IOM) defined a CPG 
as a recommendation tool to help practitioners in clinically based patient decision-making 
after a systematic review of literature and evidence has been completed. Kredo et al. 
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(2016) supports the purposes of CPGs to standardize variations in practice, help improve 
measurable quality care, and reduce adverse events. 
Practice-Focused Question 
While patients’ medical history and preprocedural instructions may be reviewed 
verbally at the local project site, the lack of formal documentation prior to procedures is 
lacking. Injectors have become dependent on a once-yearly GFE, even though patients 
may receive varying treatments throughout the year. More importantly, patients’ medical 
history and active medications may change more often than annually, requiring further 
investigation and review by the injector before each medical aesthetic treatment (De 
Boulle & Heydenrych, 2015).  
The practice-focused question for this project is: Can  the development of a CPG 
for aesthetic providers increase their knowledge about delivering safe and consistent 
patient care? In reviewing the literature, evidence on protocols and guidelines particular 
to nonsurgical aesthetic procedures was limited. However, evidence and guidelines exist 
in the field of medical aesthetic surgery and dermatology, where such procedures are also 
performed. The AMSPA has many published articles on rules, laws, and regulations 
pertaining to nonsurgical aesthetic procedures. AMSPA (2018) has reported that liability 
for physicians and nonphysician providers in aesthetics continues to rise as more 
nonsurgical aesthetic procedures are developed. This CPG can help to improve care 
outcomes and safety and reduces injectors’ liability by adding official documentation to 
patients’ medical record that a mini GFE was documented prior to treatment.  
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Sources of Evidence 
My search for evidence revealed 205 related academic journal articles and 
publications. Of these 205 articles, I selected 31 that aligned with the DNP project. I used 
the following keywords in my search: AGREE II, best practice, clinical practice 
guidelines, Melnyk and Fineout-Overholt rating system of hierarchy of evidence, theory 
in aesthetics, rules and regulations, medical spas in California, lawsuits with med spas, 
California med spa laws, California Board of Nursing, California Board of Medicine, 
good-faith exam, trouble for med spas, patient safety, safety in aesthetics, aesthetic 
dermatology, cosmetic dermatology, best practice, physician supervision, adverse events 
in aesthetics, and medical procedures by nurses. Along with the Walden University 
Library, the following databases were used: CINAHL, ERIC, PubMed, Medline, and 
BioMed Central.  
Evidence collected for this CPG project was appraised using the MFRS hierarchy 
of evidence rating system. The evidence selected for this CPG was rated and organized in 
Appendix A. In searching literature, only information that was evidence-based, recent, 
and relevant to the CPG was chosen. Chosen literature involved lack of protocols and 
regulations in the aesthetic field and prevalence of adverse events in med spas as well as 
lack of guidelines. Furthermore, I also focused on addressing patient safety, prevalence of 
adverse events due to aesthetic procedures, and trends involving why such adverse events 
were occurring according to current literature.  
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Evidence Generated for the Doctoral Project 
In this section, I provide information about evidence that was generated for this 
CPG project. This section includes information about participants, procedures, and 
protections that supported the development of this evidence-based CPG. 
Participants 
Participants included an expert panel that consisted of individuals who have 
extensive experience in the field of aesthetics practice. Their feedback was instrumental 
during the final development of the CPG. This expert panel was made up of six members, 
including one attending physician owner, one general manager, one PA, one NP, and two 
RNs.  
Procedures 
The CPG was developed after the Walden University Institutional Review Board 
(IRB) approved the project. After approval by the Walden University IRB (#06-23-21-
1021061), the CPG was developed using the following steps: 
• Appraise evidence collected from the literature search. 
• Synthesize evidence. 
• Develop the guideline/recommendations. 
• Identify an expert panel. 
• The expert panel reviews the guideline using the AGREE II instrument to 
validate the content. 
• The expert panel scores the AGREE II Instrument.  
• Revise the guideline based on recommendations. 
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• Identify groups of stakeholders and end users. 
• Present the revised guideline to end users, /key stakeholders, and /local 
experts and discuss to validate content and ensure usability. 
• Develop a final report. 
• Disseminate the final report to key stakeholders. 
 The AGREE II model was used to develop this CPG for aesthetic procedures. The 
CPG was presented to an expert panel for feedback with detailed instructions on its use. 
To evaluate the CPG, the expert panel was asked to rate various items from each domain 
of the AGREE II on a four-point scale: strongly agree (1), agree (2), disagree (3), and 
strongly disagree (4). The expert panel members used the AGREE II questionnaire to 
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Table 3 













Domain 1: Scope & Purpose 
The population (patient, public, etc.) to 
whom the guideline is meant to apply is 
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Domain 4: Clarity of Presentation 












Domain 5: Applicability  
The guideline provides advice and/or tools 
on how the recommendations can be put 










Domain 6: Editorial Independence 
The views of the funding body have not 










Note. From “AGREE II: Advancing Guideline Development, Reporting and Evaluation 
in Healthcare,” by the AGREE Research Trust (2010). Reprinted with permission. 
 
Protections 
 The development of this CPG involved searching and synthesizing evidence and 
did not involve patients. An expert panel comprised of administrative personnel reviewed 
and provided feedback and recommendations on the guideline. Based on 
recommendations, the CPG was revised and finalized. Names of expert panel members 
using the AGREE II tool questionnaire were not required to support the confidentiality of 
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evaluation results from the expert panel members. The name of the CPG implementation 
site was also not included in the final report. Permission to conduct this project was 
obtained from the Walden University IRB (#06-23-21-1021061), and the IRB approval 
criteria were maintained.  
Analysis and Synthesis 
The CPG was evaluated and graded using the AGREE II tool questionnaire (see 
Table 3) after review by the expert panel. Each related article used to support the 
development of this CPG was appraised and graded using the MFRS of hierarchy of 
evidence and organized in a table (see Appendix A). Because of the limited availability 
peer-reviewed articles on efficacy of safety protocols in the field of nonsurgical aesthetic 
treatments, peer-reviewed articles involving the associated fields of dermatology and 
cosmetic surgery were also used to support the CPG. The limited number of peer-
reviewed articles was one of the driving forces for the development of this CPG. 
Information to support the development of this CPG was also garnered from professional 
organizations and professional licensing boards. The development of the CPG, evaluation 
by the expert panel, recommendations from the expert panel, and final CPG report are 
discussed in Section 4. 
Summary 
To date, there is no CPG focused on standardizing care that can lead to enhancing 
patient care outcomes and patient and provider safety that can be used to guide aesthetic 
injectors prior to the delivery of nonsurgical aesthetic procedures. The development of 
this evidence-based CPG is the first of its kind to provide guidance for injectors when 
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performing aesthetic procedures. The CPG will help to fill this gap in practice and 
available literature in the field of aesthetics. This project was presented to an expert panel 
comprised of members who were experienced in the nonsurgical aesthetic field. Changes 
to the CPG were made according to feedback from this panel.   
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Section 4: Findings and Recommendations 
Introduction 
This doctoral project focused on establishing a CPG to improve provider 
knowledge and practice, through providing guidance to aesthetic providers when 
performing nonsurgical procedures. At the local practicum site, nurses and other aesthetic 
providers lack evidence-based guidelines to help them review safety protocols before 
performing aesthetic procedures for patients presenting to the clinic. To date, this project 
serves as the first of its kind in the field of nonsurgical aesthetics, with a focus to help fill 
the existing gap in literature and practice as an evidence-based safety-oriented practice 
guideline to streamline aesthetic services. The lack of standardization in practice resulted 
in the practice gap that led to undesired patient outcomes that resulted from aesthetic 
procedures, which compromised patient safety and increased litigation risks for aesthetic 
providers. 
While annual GFEs are currently being performed at the practice site, there was 
no documentation that aesthetic providers were screening and documenting reviews of 
patients’ medical history before every aesthetic procedure after that initial GFE. 
Reviewing patients’ medical history before any medical treatment helps reduce adverse 
events and side effects of treatments (Chhabra et al., 2019; Kim et al., 2015). The 
practice-focused question for this DNP project asked: Can the development of a CPG for 
aesthetic providers increase their knowledge about delivering safe and consistent patient 
care?           
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The purpose of this project was to address the practice-focused question by 
creating this evidence-based CPG to help guide nurses and other aesthetic injectors in 
streamlining the screening process of patients before performing any aesthetic procedure. 
The CPG can help improve provider knowledge while bridging the gap in practice and 
improving patient safety. Kredo et al. (2016) supports the use of CPGs and shared that 
CPGs had become a foundation in practice, helping to guide evidence-based policy. 
Furthermore, literature highlighted the importance of such CPGs in standardizing 
variations in practice while also helping to improve the quality of care. 
Sources of Evidence and Analytical Strategies 
Sources of evidence were obtained using online databases to search for problems 
in the aesthetic field relating to lack of practice guidelines for aesthetic procedures. In 
searching for evidence through the Walden University Library, CINAHL, ERIC, 
PubMed, Medline, and Bio-MedCentral databases were used.  I also focused on evidence 
related to patient safety during aesthetic procedures and protocols for improving such 
safety in the fields of dermatology and plastic surgery. Established safety measures from 
the field of dermatology and plastic surgery were incorporated into this CPG. The 
evidence I used in developing this guideline was appraised using the MFRS hierarchy of 
evidence rating system. As previously identified, expert panel members were individually 
educated about AGREE II criteria via a written introductory statement and instructions 
(see Appendix B). A summary that included the purpose of the CPG was provided to the 
expert panel. Of the six expert panel members, five were also end users.  
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Findings and Implications 
The expert panel evaluated the CPG using AGREE II evaluation survey criteria. 
Based on their evaluation, survey responses from the expert panel revealed support for 
the guideline and a high interest in instituting the guideline at the local practicum site. 
The expert panel’s high evaluation scores of this CPG were due to the strength and 
completeness of the project. Comments and suggestions made by some of the expert 
panel members indicated the importance and need for such a project at the local 
practicum site: 
• Domain 1 - Scope and Practice: All six reviewers strongly agreed that the 
CPG accurately and clearly described the population for whom the 
guideline is intended.  
• Domain 2 - Stakeholders’ Involvement: All six reviewers strongly agreed 
that the CPG clearly defined the intended target users. The expert panel 
included professionals involving all intended users of the CPG (two RNs, 
one NP, one PA, and one MD) to ensure their involvement in the 
development, review, and approval of this CPG.  
• Domain 3 - Rigor of Development: All six reviewers agreed that the CPG 
was developed using systematic methods to search for incorporated 
evidence. This confirmed the reviewers’ unified support of criteria used to 
search for evidence.  
• Domain 4 - Clarity of Presentation: Five members of the expert panel 
strongly agreed that components of the CPG were clearly presented, One 
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reviewer disagreed and provided feedback that grammatical errors needed 
to be revised. This recommendation was embraced and addressed. Future 
researchers can modify expert panel information to clarify that grammar, 
while not part of the evaluation process rating when using the AGREE II 
questionnaire, was important to the guideline’s content and clarity and was 
also appreciated. If grammatical issues impact the clarity of the CPG, the 
CPG developer should be contacted immediately to resolve content 
feedback. 
• Domain 5 - Applicability: Four out of six reviewers strongly agreed 
regarding the applicability of the CPG. One reviewer added that the CPG 
provides advice and tools on how recommendations can be put into 
practice. One reviewer disagreed and provided feedback that grammatical 
errors needed revision. This feedback was embraced and addressed like 
noted in domain 4.  
• Domain 6 - Editorial Independence: All six reviewers strongly agreed that 
there was no funding involved in this project; therefore, there was no 
influence on the content of the CPG, and editorial independence was 
maintained.   
Table 4 includes the expert panel’s evaluation scores of this CPG based on 
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Unanticipated Outcomes 
As a part of this DNP project, the CPG was developed with the intention to 
implement it at the practicum site. However, due to limited time and the transition of the 
practicum site’s method of documentation from paper charting to electronic charting via 
electronic medical record (EMR) software, it was not possible to develop and implement 
the guideline simultaneously. Nonetheless, project site administrators plan to implement 
this CPG after the completion of this DNP project and in the near future.  
 Only one expert panel member rated Domains 4 and 5 as “Disagree” as shown in 
Table 1 and commented that these domains “need grammatical revisions.” Statistically, 
this evaluation response is considered an outlier compared to median results of the 
evaluation by other expert panel members. This suggests that ratings on these two 
domains were due to grammatical errors; there was no comment that the rating was based 
on the content of the guideline in these domains. Grammar while not a criterion of the 
AGREE II evaluation tool, is an expectation to support content and clarity. Nonetheless, 
evaluation decisions by other panel members supported domains 4 and 5. After reviewing 
the expert panel’s evaluation results, the CPG was reviewed and revised. All 
recommended changes were made, including any that related to grammar that remained. 
Due to the unanticipated outcome relating to grammar, changes to instructions provided 
to future expert panel evaluators can be made regarding immediate notification of the 
project leader about grammatical concerns, especially if the grammatical concerns impact 
the clarity of the CPG’s content and clarity of content. The project leader’s contact 
information should be highlighted as a part of the CPG’s instruction, as it was for this 
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CPG. Reiterating that panelists focus on content, structure, and clarity of information 
presented in the CPG per the AGREE II tool as a part of instructions could also add 
clarity to the evaluation process.  
Individual Implications 
 More information is needed in the aesthetic field to help guide injectors. CPGs 
such as this are needed to help inform healthcare provider practice. The project findings 
align with this DNP project’s aim to support healthcare providers working in the aesthetic 
field. The time it takes an individual injector to complete the mini GFE is about one 
minute. This additional effort by injectors helps to improve their knowledge of the 
patient’s medical history and possible contraindications to treatment, as well as patient 
outcomes. Incorporating this CPG, which includes this additional mini GFE step, can 
furnish providers with a safe evidence-based care protocol to use as a guide when 
providing aesthetic treatments.  
Community Implications 
 The literature stressed the association of lack of protocols available to aesthetic 
providers and the impact on poor patient outcomes, resulting in increasing litigation risks. 
Using the developed CPG, medical facilities offering nonsurgical medical aesthetic 
treatments can benefit from incorporating a standardized care process that can provide a 
safer approach to care for patients. Furthermore, incorporating this CPG can help 
improve injector knowledge about practice safety and proper federal protocols, which can 
improve patient outcomes and have a positive impact on the aesthetic community.  
  41 
 
Institutional Implications 
 There is a gap in proper and consistent clinical practice at the local project site, 
including the lack of a CPG to support treatment administration and documentation. A 
documented review of patients’ medical history prior to providing each aesthetic 
treatment was not found in medical records. While medical records reflected that annual 
GFEs were being documented, there was no guideline in place that required assessment 
of patients’ medical history prior to each patient procedure. This CPG will help reduce 
and/or eliminate that gap in practice to ensure that aesthetic providers deliver 
standardized care that can result in safer patient care. Once the CPG is implemented, the 
institution’s administrators can communicate changed and improved practice standards 
that can increase level of safety for patients seeking care there.  
System Implications 
 Nonsurgical aesthetic procedures such as neurotoxins and dermal fillers at med 
spas are considered medical treatments, and as such, are regulated by state medical board 
(MBOC, 2020). Individuals such as RNs and NPs must ensure that they are following 
guidelines set by boards of nursing in their respective states, in addition to what particular 
institutions may impose. Using the developed CPG, injectors can have a standardized 
practice process requiring that GFEs are completed at least once annually, and mini GFEs 
are completed prior to every subsequent procedure. Once the CPG is implemented at the 
project site, the organization can incorporate this CPG at other partner med spas, 
providing a system-wide practice standard. 
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Implications for Positive Social Change 
This CPG can serve as a system-wide standardized practice approach for the 
project site, other associated sites, and aesthetic institutions nationally and globally. This 
CPG can prevent aesthetic providers from experiencing unnecessary practice and 
procedural issues that can result in the need to halt procedures and institute resolutions. 
Standardized aesthetic treatments can help improve patient safety, reduce adverse events, 
and improve patient outcomes. Positive social change can be achieved through the 
application of a standardized practice protocol like this CPG at the project site system-
wide, locally, nationally, and globally. 
This CPG can also serve as a resource for other medical practices providing 
aesthetic treatments. For those currently practicing or institutions currently offering care 
in the field of aesthetic medicine without a CPG, it is my recommendation that a CPG be 
incorporated to provide a safer and standardized approach to clinical practice that can 
improve patient outcomes and reduce litigations. I recommend that individuals and 
institutions conduct their research and consult an attorney familiar with med spa practices 
prior to adopting and implementing this or any other CPG supporting aesthetic care. 
Applying a standardized practice protocol like this or other CPGs can further enhance 
positive social change by supporting aesthetic injectors and providing a safer approach to 
aesthetic treatments. 
Recommendations 
It is the responsibility of each licensed professional (RN, NP, PA, MD, DO) to 
ensure that they are following their respective state licensing board guidelines regardless 
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of protocols that maybe imposed at any particular med spa agency. This CPG should not 
be constituted as a replacement to any state regulations on the administration of 
neurotoxins, dermal fillers, or any other medical aesthetic procedure. However, given the 
evidence provided and rigor in developing this CPG, it is recommended that the project 
site take advantage of incorporating a standard of care. This CPG, which is presented in 
Appendix B, was developed as a standard of care for aesthetic procedures performed at 
the project site. If instituted at the project site, I also recommend that this CPG be 
reviewed at least annually to determine if revisions are needed to assure that the guideline 
continues to meet the needs of the institution, its providers, and patients. 
Strengths and Limitations of the Project 
Strengths 
This CPG was developed using current evidence-based literature to enhance its 
rigor. An expert panel at the local practice site with many years of experience in the 
aesthetic field evaluated the CPG using the six domains of the AGREE II guideline 
evaluation tool. The evaluators provided primarily positive feedback in their evaluations. 
Despite one member rating two domains as less than “agree”, the rest of the expert panel 
rated the six domains as either “strongly agree” or “agree”, with the majority of responses 
coinciding with “strongly agree” as presented earlier in Figure 1. Best related evidence 
from the fields of medical aesthetic surgery and dermatology were used to help support 
and develop a CPG that can improve patient outcomes and safety. Resources from the 
AMSPA were also used to help clarify legal regulations and discussions involving the 
performance of aesthetic procedures. 
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Limitations  
A significant limitation of this CPG was the lack of existing clinical guidelines in 
the aesthetic medicine industry. Another limitation was the lack of published evidence in 
the field of aesthetics to support this guideline. Because of the limited evidence available 
in aesthetics, evidence was garnered from the fields of aesthetic surgery and dermatology.  
The DNP project was limited as projects’ scope would not include the implementation of 
the guideline and therefore would not include the measurable data that would arise from 
the outcome of the guideline’s use and the benefit to the project site. Analysis of end-user 
feedback could have proven useful in future clinical projects, in the development of 
similar CPGs, and other practice sites. Issues with compliance and user and 
administrative feedback could not be obtained without implementation, which is also a 
limitation to this project. While guideline implementation was my original goal for this 
project, time and other site constraints impaired such an achievement from happening.  
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Section 5: Dissemination Plan 
Although the literature supports significant advancements to nursing knowledge 
through project developments such as CPGs, lack of dissemination of such CPGs has 
contributed to the gap between available evidence-based literature and application in 
clinical practice. Dissemination of CPGs can help fill that gap and increase the 
prevalence of CPGs in practice. The final CPG will be disseminated to the expert panel 
and other staff members during a lunch meeting at the practicum site to facilitate end-user 
discussions with other interested parties prior to site implementation. Once implemented, 
this CPG will also be incorporated into the organization’s standard procedures and 
protocols manual that is available to all employees at any time for reference.  
Another means of disseminating this DNP project is an oral presentation at the 
Medical Spa Show 2022 hosted by the AMSPA. If approved for presentation, this venue 
will lead to significant exposure of the CPG and DNP project to some of the world’s top 
aesthetic injectors, as this show is a highly anticipated annual event. A link to this DNP 
project will be provided to audience members as a resource for future review of the 
project in more detail. This link will also provide the show and conference audience with 
an opportunity to print and download the CPG for further review or incorporation into 
their own aesthetic practices.  
Disseminating this DNP project on social media can also help in filling the 
clinical practice gap. One of the barriers to research implementation that has been 
relevant in the literature is the lack of a dissemination venue that incorporates feedback 
loops, or a way of allowing the targeted audience to express their thoughts on any given 
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project presentation. Social media outlets like Facebook and Instagram allow users to 
engage in open communication through messages and videos. The CPG will be presented 
on social media through a PowerPoint video presentation to encourage other aesthetic 
providers to review and possibly incorporate into their own practices.  
This evidence-based CPG can be disseminated to medical clinics that provide 
nonsurgical aesthetic treatments such as neurotoxins and dermal fillers. Administrators 
and providers can align the CPG to their respective state guidelines and institutional 
policies. Although this CPG has incorporated information from regulatory agencies in the 
state of California, it can be applied to medical spas in any state, regardless of state law, 
as objectives include streamlining aesthetic services and improving patient outcomes.   
Analysis of Self 
Conducting a clinical practice project and DNP project findings provided me with 
tools as a nursing scholar as well as advancing the fields of nursing and aesthetics. The 
experiences I gained in the development of this DNP project allowed me to become more 
knowledgeable about the process of change that included factors such as facilitators, 
barriers, and the importance of stakeholder involvement. Developing this project also 
allowed me to learn how to better work through organizational channels and reach and 
identify the relevant audience when seeking support for a change project. 
Searching and collecting best evidence and sources of evidence for this DNP 
project posed a challenge due to the current lack of scholarly resources and relevant 
information about nonsurgical aesthetic practices. As the aesthetic field continues to 
evolve, more researchers, clinical project leaders, and innovators are needed to help 
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develop evidence-based CPGs that provide up-to-date protocols. Another challenge was 
researching laws and regulations which govern aesthetic treatments. To date, there 
remains no regulatory body that specifically regulates nonsurgical aesthetic procedures. 
Currently, nurses and other aesthetic professionals are dependent on vague guidelines, 
word of mouth, and what is considered to be common practice when providing aesthetic 
treatments. The future dissemination of this DNP project will help nurses and other 
aesthetic providers by addressing the importance of being informed, proper training, and 
providing standardized care when performing aesthetic procedures.  
Over the past 4 years, I have had the privilege of working at multiple medical spa 
clinics in Michigan and California. I have also had the privilege of training with some of 
the nation’s top aesthetic providers, constantly advancing my injection techniques for 
improved patient outcomes and safety. Working for a growing organization has further 
contributed to my growth as an aesthetic provider because of the value the organization 
places on growth and development.  
After the DNP project is approved and implemented at the project site and my 
DNP degree from Walden University has been conferred, I plan to further advance my 
position with my current employer becoming the head of the aesthetics department 
responsible for overseeing and training novice injectors. As the head of the aesthetics 
department, my responsibilities would be to develop policies, procedures, and CPGs, as 
well as train other injectors about various aesthetic procedures. Supervisory duties also 
include evaluating aesthetic injectors’ performance to ensure proper safety protocols are 
being followed. As part of my long-term professional goals, I strive to become a public 
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figure on social media, advocating for safe and consistent treatment and educating other 
aesthetic providers.  
Summary 
This DNP project involved developing an evidence-based CPG to fill the gap in 
practice related to the lack of a CPG for aesthetic injectors at the project site. This CPG 
provides a streamlined approach when screening patients presenting for nonsurgical 
aesthetic procedures that can be applied at the project site and other medical facilities that 
offer nonsurgical aesthetic procedures. The CPG also serves as a simple yet effective tool 
to assist aesthetic injectors in following a standardized practice guide, which incorporates 
state and regulatory guidelines that can improve patient outcomes. This CPG can 
empower new and novice aesthetic injectors to become more knowledgeable about 
standard rules and regulations of providing safe and standardized nonsurgical aesthetic 
treatments with an aim to improve patient safety that can serve to reduce legal 
ramifications.  
Implementation of this CPG at a practice site will help standardize patients’ 
documentation and screening processes prior to nonsurgical aesthetic procedures. CPGs 
such as this have become a standard in clinical practice. By applying this or another 
evidence-based CPG at their respective practice sites, nurses and other aesthetic 
professionals can help to streamline the implementation of aesthetic procedures, improve 
patient outcomes, and positively impact social change. 
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Appendix A: Literature Matrix 
Authors Year Name of 
Journal or 
Book 
Title Summary Evidence 
Level 






issues in the 
medical spa 
industry 
National survey of 
medical spas to collect 
data about the growth 
of the industry and 
legal and regulatory 
issues. Expert opinion 
by attorneys who focus 
their work on legal 
cases in the medical 
spa industry.  
VII 








the safety of 
medical spas 
Authors identified that 
medical spas had a 
higher incidence of 
adverse events than a 
traditional physician’s 
office. Most adverse 
events occurred due to 




Singh, A., Kuka, 
P., Kaur, H., Kuka, 















An observational study 
that stressed the 
importance of 
reviewing a patient’s 
medical history and 
safety checklist prior to 
surgery to help reduce 
adverse events. 
Concluded that most 
adverse events 
occurred because of 
errors that were 
overlooked prior to or 
after surgery.  
IV 





Study stresses the 
importance of proper 
training of injectors 
after finding that many 
legal ramifications 
occurred due to lack of 
training or proper 
supervision.  
IV 
Kim, F., Da Silva, 
R., Gustafson, D., 
Nogueira, L., 
Harlin, T., & Paul, 
D. 








focused on the 
importance and need 
for standardized 
practice guidelines in 
surgeries to help 
VI 
  56 
 
improve safety and 
prevent adverse events.  











Expert knowledge on 
the prevention and 
treatment of the 
number one adverse 
event of cosmetic 
treatments, bruising. 
The authors support 
the need for pre-
treatment evaluations 
and review of medical 
history to help prevent 
adverse events.  
VII 
Rossi, A., Wilson, 





practice of  
cosmetic 
dermatology: 






more adverse events 
from medical spas 
outside the traditional 
physician office, 
questioning the 
training and safety 
protocols in place at 




Moore, S. et al. 














of a national 
guideline 
In randomized 
controlled trial, authors 
concluded the 
importance of using 
the Theoretical 
Domains Framework 
in implementing a 
guideline as compared 
to the control group.  
II 













Importance of medical 
history review to help 
improve patient safety 
and prevent adverse 
events from cosmetic 
treatments. Authors 
discussed medications 
that may be 
contraindicated if 
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Appendix B: Medical Spas: Ensuring Compliance and Patient Safety 
Objectives:  
1. Standardize the Medical Spa treatment processes.  
2. Increase aesthetic injector knowledge and treatment practices about care standards 
on providing medical treatments for patients. 
3. To enhance treatment compliance and patient safety. 
Problem Statement -Can the development of a clinical practice guideline (CPG) for 
aesthetic providers increase their knowledge about delivering safe and consistent patient 
care?           
Target Population - Aesthetic injectors employed (Registered Nurses (RNs), Nurse 
Practitioners (NPs), Physician Assistants (PAs), and Medical Doctors (MDs).                 
Guideline Monitoring -The medical assistant is currently responsible for ensuring that 
all necessary patient forms are completed prior to beginning treatment such as patient 
consent forms and arbitration agreements. This will be a continuous process, as the 
injector assistant will ensure that the injector for every patient’s physical chart has 
completed the CPG questionnaire before filing it. Monthly reviews of charts by the MD 
of the practice will ensure continuous monitoring of guideline compliance.                                                                                
Introduction                                                                                                                                                               
As advancements in nonsurgical medical aesthetics procedures continue to evolve, state 
and federal policies providing clear, up to date, safety and legal guidelines for such 
procedures performed at medical spas are limited or lacking. The terms physician and 
MD are used interchangeably in this guideline. The terms NP, PA and non-physician 
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providers are also used interchangeably in this guideline. As more people come forward 
with complications resulting from nonsurgical procedures performed by improperly 
trained providers, state regulatory agencies have begun to increase enforcement of state 
guidelines violations (AMSPA, 2018). Goldberg (208) said that many medical spas and 
operators that have faced legal ramifications were due to a lack of proper supervision of 
medical treatments as well as improperly trained personnel. Non-compliance with state 
and federal laws and professional scope of practice, compromise patient safety, impact 
patient outcomes, and increase the potential for litigation.                                                                                                                
Part I – Initial Good Faith Exam (GFE)                                                                                        
An initial GFE must be conducted on each patient once they present for services during 
their first visit. The patient must have an initial GFE completed and documented by a 
physician or a non-physician provider within the last 365 days for the followup GFE 
(mini GFE) to be initiated. The initial GFE must be documented and completed per 
existing organization protocol at least every 365 days.                                                                                                                             
Part II – Follow up Good Faith Exam (mini GFE)                                                                     
The mini GFE evaluation form is to be completed for every patient visit by the injector 
prior to the administration of any aesthetic medical treatment. This mini GFE evaluation 
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Clinical Practice Guideline: Improvement of Injector Knowledge and Patient Safety  
1. Has the patient had a GFE performed in the last 
year?  
YES: ¢ : Continue to the next question.  
NO:   ¢ : Stop here and perform a GFE per your 
organization protocol.  
 
2. Does the patient have any bleeding disorders or 
has the patient taken (NSAIDS), aspirin-
containing products,  or herbal supplements 
(ginkgo biloba, folic acid, turmeric, melatonin, 
garlic, coenzyme Q, cayenne, kava kava, ginger, 
etc.) in the last 7 days?  
 
YES: ¢ : Please advise the patient on the 
increased risks for bleeding, bruising, and skin 
sensitivities that may occur during procedure. Give 
the patient the options to continue with treatment or 
to reschedule the service.  
NO:   ¢ : Continue to the next question.  
 
3. Has the patient had any changes in their medical 
history since the last good faith exam, particularly 
any new skin conditions or other conditions that 
may deem to be contraindicated by the injector? 
 
YES: ¢ : If there are questionable 
contraindications, please contact the physician or 
non-physician provider to discuss and clarify 
concerns prior to performing the treatment.  
NO:   ¢ : Continue to the next question 
 
4. Has the patient reviewed, signed, and understands 
all the pre and post-procedure instructions given 
to them for the treatment being performed today? 
 
YES: ¢ 
NO:   ¢ : Please review pre and post-procedure 
instructions with patient for clarity.  
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Med Spa Compliance 
and Safety Guideline 
Components 
(Collected from the 
evidence/literature) 














Part I: Ensure a GFE 
has been performed. If 
a GFE has not been 
performed, the injector 
must then ensure that a 
GFE is performed 
using established 
organization guidelines.  
Always ensure that a 
GFE has been 
performed within 365 
days prior to 
providing any 
medical treatment. 














by a physician 





Part II: Does the patient 
have any bleeding 





and or herbal 
supplements (ginkgo 
biloba, folic acid, 
turmeric, melatonin, 
garlic, coenzyme Q, 
cayenne, kava kava, 
ginger, etc.) in the last 
7 days? 
If the answer is YES, 
Please advise the 
patient on the 
increased risks for 
bleeding, bruising, 
and or skin 
sensitivities that may 
occur during 
procedure. Give the 
patient the option to 
continue with 
treatment or to 
reschedule. 













that may be 
contraindicate









Has the patient had any 
changes in their 
medical history since 
the last good faith 
If the answer is YES, 
and if there are 
questionable 
contraindications, 















exam, particularly any 
new skin conditions or 
other conditions that 
may deem to be 
contraindicated by the 
injector? 
please contact the 
physician or non-
physician provider to 























prior to or 
after surgery. 
Has the patient 
reviewed, signed, and 
understands all the pre 
and post instructions 
given to them for the 
treatment being 
performed today? 
If the answer is NO, 
please review pre and 
post-procedure 
instructions with 
patient for clarity. 















and review of 
medical 
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Rationale Supporting Guideline Questions: Why should we ask these questions? 
Question 1: Has the patient had a GFE performed in the last year? If the answer is 
“Yes”, then the injector can continue with the CPG while if the answer is “No”, the 
injector will discontinue the CPG and request that the annual GFE with a physician or 
non-physician provider be performed with the patient prior to initiating any medical 
treatment. At the local practicum site, there have been many incidences where an injector 
would forget to check a patient’s file to ensure that a GFE had been previously done and 
if within the past 365 days. The patient would leave the clinic after receiving a medical 
treatment, many times performed by an RN. If a nurse injector performs medical 
treatments without standing orders from a physician or non-physician provider, the nurse 
could be in violation of both state and federal guidelines for the unlawful practice of 
medicine (CBON, 2013). For many reasons, this can put the injector’s license at risk 
while leaving the nurse, the medical director, and the med spa organization, open for 
litigation and impact patient outcomes (AMSPA, 2018). 
Question 2: Does the patient have any bleeding disorders and/or has taken non-
steroidal anti-inflammatory (NSAIDS) (ibuprofen, Motrin, Advil, Aleve), aspirin 
containing products, and or herbal supplements (ginkgo biloba, folic acid, turmeric, 
melatonin, garlic, coenzyme Q, cayenne, kava kava, ginger, etc.) in the last 7 days? If the 
answer is “Yes”, the injector is to educate the patient on this risk and a joint decision 
between the patient and the provider is made if the patient would like to continue with the 
procedure or to re-schedule. If the patient has consumed any of these medications within 
the past 7 days, the procedure can be performed; however, the patient must be informed 
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that they are at increased risk of possible bruising and or bleeding during the procedure 
and should be provided the option of re-scheduling their procedure. The use of such 
products prior to nonsurgical cosmetic treatments has been shown to increase the 
prevalence of bleeding and contusions during and after treatment. In fact, bruising has 
been noted as the most common adverse event from dermal filler and botulinum toxin 
injections. Results showing the prevalence of bruising after such treatments have ranged 
from 19% to as high as 68% and can last for longer than two weeks. The number one 
complaint from patient dissatisfaction has been extensive bruising (King, 2017).  
Question 3: Has the patient had any changes in their medical history since the last 
good faith exam, particularly any new skin conditions or other conditions that may deem 
to be contraindicated by the injector? If the answer is “Yes”, the injector will decide 
whether or not a contraindication exists. If the injector is an RN and there is questionable 
doubt of possible contraindications, he or she must initiate a telephone consult with the 
physician or non-physician provider prior to the treatment. Reaching out to the physician 
or non-physician provider for further evaluation of the patient’s medical changes will 
ensure that the RN is practicing within his/her scope of practice (CBON, 2013).  
Question 4: Has the patient reviewed, signed, and indicated understanding of all 
the pre and post procedure instructions given to him/her for the treatment being 
performed today? If the answer is “No”, it is recommended that these instructions be 
discussed with the patient prior to administering any treatment so that all questions and 
concerns are addressed. It is a standard of practice for patients to sign consent forms for 
treatments as well as sign pre and post-procedure instructions to ensure that any questions 
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or concerns are addressed prior to the treatment. At the project site, unfortunately these 
forms are signed for all available treatments from the date of the patient’s initial GFE and 
are not routinely reviewed with the patient prior to any and all of the scheduled 
treatments thereafter. The American Med Spa Association (AMSPA), reports that 37% of 
respondents to a survey related to the GFE admitted either the GFE wasn't being 
performed or, that the physician, PA, or NP was not the one performing the initial exam 
(Adatto & Byrd, 2017). Prior to administering any medical treatment to a patient, the 
CPG will provide a guideline-directed process that includes steps for the injector to 
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Appendix C: Expert Panel Evaluation 
Thank you for your participation in the evaluation of this clinical practice 
guideline (CPG). Your feedback is critical to the success and further development of this 
CPG. Please fill out the following questionnaire by choosing one rating for each of the 
six domains listed below ranging from strongly agree to strongly disagree.  














Domain 1: Scope & Purpose 
The population (patient, public, etc.) to 
whom the guideline is meant to apply is 










Domain 2: Stakeholders’ Involvement 











Domain 3: Rigor of Development 











Domain 4: Clarity of Presentation 











Domain 5: Applicability  
The guideline provides advice and/or tools 
on how the recommendations can be put 










Domain 6: Editorial Independence 
The views of the funding body have not 










Note. From “AGREE II: Advancing Guideline Development, Reporting and Evaluation 
in Healthcare,” by the AGREE Research Trust (2010). Reprinted with permission. 
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Appendix D: AGREE II Permission 
 
 
        February 02, 2021 
 
 
To Mike Chammout and Walden University,  
 
We, the AGREE Enterprise Research Office, give permission to Mike Chammout and his co-
authors to use the AGREE II tool, in his publication: “Medical Spas: Ensuring Compliance 
and Safety.” 
 
This permission provided that the authors properly cite the AGREE II tool in the mentioned 
article.  
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